Testing Gocovri for radiation-related brain injury
Part of Brain & nervous system clinical trials.
This trial tests if the drug Gocovri can help people who have brain changes from past radiation treatment. It aims to reduce disability caused by radiation encephalopathy, a condition that affects thinking and movement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a caregiver who can help fill out surveys.
- You have had radiation treatment to the brain before.
- You have specific brain scan findings from an MRI done in the last 5 years.
- You are not pregnant or breastfeeding and agree to use contraception if needed.
- You are not currently taking or have not taken Amantadine or similar drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if bevacizumab works better than steroids for people with brain swelling caused by radiation. If you have this condition and meet certain health requirements, you may join.
This trial tests a new oral drug called XRD-0394 given together with radiation therapy for people with high-grade glioma, a type of aggressive brain tumor. The goal is to see if adding this drug makes radiation more effective.
This trial tests whether starting two medicines early can help protect your memory and thinking abilities after whole-brain radiation for cancer that has spread to the brain. You would take memantine and pioglitazone while undergoing standard radiation treatment.
This study uses MRI scans and related brain/cognitive testing while you receive standard chemotherapy and radiation for a high-grade brain tumor. It aims to see how MRI measures and brain testing may relate to your treatment response or brain function.
This trial studies how radiation therapy affects thinking and memory in adults with certain brain tumors. It may help doctors understand which patients are more likely to have cognitive side effects and how to measure them over time.
This trial tests whether a new drug called VRT106, given alongside radiation therapy, can help treat a serious type of brain tumor called diffuse midline glioma or DIPG. The drug is designed to work with radiation to fight the cancer.
Hear when a new Encephalopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.